Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL–initiating cells
- 12 January 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (2), 494-502
- https://doi.org/10.1182/blood-2011-06-359232
Abstract
The characterization and targeting of Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)–initiating cells remains unresolved. Expression of the polycomb protein Bmi1 is up-regulated in patients with advanced stages of chronic myelogenous leukemia (CML). We report that Bmi1 transforms and reprograms CML B-lymphoid progenitors into stem cell leukemia (Scl) promoter-driven, self-renewing, leukemia-initiating cells to result in B-lymphoid leukemia (B-ALL) in vivo. In vitro, highly proliferating and serially replatable myeloid and lymphoid colony-forming cultures could be established from BCR-ABL and Bmi1 coexpressing progenitors. However, unlike in vivo expanded CML B-lymphoid progenitors, hematopoietic stem cells, or multipotent progenitors, coexpressing BCR-ABL and Bmi1 did not initiate or propagate leukemia in a limiting dilution assay. Inducible genetic attenuation of BCR-ABL reversed Bmi1-driven B-ALL development, which was accompanied by induction of apoptosis of leukemic B-lymphoid progenitors and by long-term animal survival, suggesting that BCR-ABL is required to maintain B-ALL and that BCR-ABL and Bmi1 cooperate toward blast transformation in vivo. Our data indicate that BCR-ABL targeting itself is required to eradicate Ph+/Bmi1+ B-ALL–initiating cells and confirm their addiction to BCR-ABL signaling.Keywords
This publication has 49 references indexed in Scilit:
- CREBBP mutations in relapsed acute lymphoblastic leukaemiaNature, 2011
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib MesylateCancer Cell, 2010
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitorsNature, 2010
- The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid LeukemiaCancer Cell, 2009
- Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrainGenes & Development, 2009
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsCell Stem Cell, 2009
- BCR-ABL-transformed GMP as myeloid leukemic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformationOncogene, 2007
- Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiationProceedings of the National Academy of Sciences of the United States of America, 2006
- Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient miceThe Journal of Experimental Medicine, 2006